Cite
Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cells.
MLA
Ni, Ming, et al. “Response to Extracorporeal Photopheresis Therapy of Patients with Steroid-Refractory/-Resistant GvHD Is Associated with up-Regulation of Th22 Cells and Tfh Cells.” Cytotherapy (Elsevier Inc.), vol. 24, no. 3, Mar. 2022, pp. 311–19. EBSCOhost, https://doi.org/10.1016/j.jcyt.2021.09.008.
APA
Ni, M., Wang, L., Ding, Y., Gong, W., Wang, S., Neuber, B., Schubert, M.-L., Sauer, T., Hückelhoven-Krauss, A., Luft, T., Hegenbart, U., Schönland, S., Eckstein, V., Wang, J., Krüger, W., Müller-Tidow, C., Dreger, P., Schmitt, M., & Schmitt, A. (2022). Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cells. Cytotherapy (Elsevier Inc.), 24(3), 311–319. https://doi.org/10.1016/j.jcyt.2021.09.008
Chicago
Ni, Ming, Lei Wang, Yuntian Ding, Wenjie Gong, Sanmei Wang, Brigitte Neuber, Maria-Luisa Schubert, et al. 2022. “Response to Extracorporeal Photopheresis Therapy of Patients with Steroid-Refractory/-Resistant GvHD Is Associated with up-Regulation of Th22 Cells and Tfh Cells.” Cytotherapy (Elsevier Inc.) 24 (3): 311–19. doi:10.1016/j.jcyt.2021.09.008.